Kovitz Investment Group Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $677K | Sell |
1,290
-5,639
| -81% | -$2.96M | ﹤0.01% | 886 |
|
|
2025
Q1 | $4.39M | Buy |
6,929
+4,154
| +150% | +$2.63M | 0.02% | 426 |
|
|
2024
Q4 | $1.98M | Sell |
2,775
-916
| -25% | -$653K | 0.01% | 572 |
|
|
2024
Q3 | $2.57M | Buy |
3,691
+1,303
| +55% | +$907K | 0.02% | 457 |
|
|
2024
Q2 | $2.51M | Buy |
2,388
+1,395
| +140% | +$1.47M | 0.02% | 393 |
|
|
2024
Q1 | $956K | Buy |
993
+753
| +314% | +$725K | 0.01% | 415 |
|
|
2023
Q4 | $211K | Sell |
240
-27
| -10% | -$23.7K | ﹤0.01% | 395 |
|
|
2023
Q3 | $220K | Buy |
+267
| New | +$220K | ﹤0.01% | 377 |
|
|
2023
Q2 | – | Sell |
-287
| Closed | -$236K | – | 428 |
|
|
2023
Q1 | $236K | Sell |
287
-30
| -9% | -$24.7K | ﹤0.01% | 391 |
|
|
2022
Q4 | $229K | Sell |
317
-1,728
| -84% | -$1.25M | ﹤0.01% | 376 |
|
|
2022
Q3 | $1.41M | Sell |
2,045
-545
| -21% | -$376K | 0.03% | 239 |
|
|
2022
Q2 | $1.53M | Sell |
2,590
-367
| -12% | -$217K | 0.03% | 238 |
|
|
2022
Q1 | $2.07M | Buy |
+2,957
| New | +$2.07M | 0.04% | 226 |
|
|
2021
Q4 | – | Sell |
-3,631
| Closed | -$2.2M | – | 441 |
|
|
2021
Q3 | $2.2M | Sell |
3,631
-314
| -8% | -$190K | 0.04% | 226 |
|
|
2021
Q2 | $2.2M | Buy |
3,945
+2,687
| +214% | +$1.5M | 0.04% | 229 |
|
|
2021
Q1 | $595K | Buy |
+1,258
| New | +$595K | 0.01% | 324 |
|
|
2020
Q2 | – | Sell |
-2,437
| Closed | -$1.19M | – | 386 |
|
|
2020
Q1 | $1.19M | Sell |
2,437
-460
| -16% | -$225K | 0.04% | 221 |
|
|
2019
Q4 | $1.09M | Buy |
+2,897
| New | +$1.09M | 0.03% | 255 |
|
|
2019
Q3 | – | Sell |
-2,133
| Closed | -$668K | – | 363 |
|
|
2019
Q2 | $668K | Buy |
2,133
+940
| +79% | +$294K | 0.02% | 296 |
|
|
2019
Q1 | $489K | Buy |
+1,193
| New | +$489K | 0.02% | 312 |
|